PPARA variant rs1800234 had a dose dependent pharmacogenetics impact on the therapeutic response to chiglitazar

Background Our objective was to explore the pharmacogenetic impact of three known functional variants in drug target genes and determine whether they can explain the inter-individual variation in therapeutic response.